Topic Paragraphs
Featured Topics
FDA.gov Website Refresh
FDA is pleased to announce the launch of our newly redesigned public website. We are making website improvements to provide a more modern and customer-centric web experience.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Recent Press Announcements
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Sep 12
Urban Remedy Voluntarily Recalls 76 Salads, Wraps That May Contain E.Coli Bacteria No Illnesses Reported, Company Taking Preventive Action
Food & Beverages
Sep 12
Darmerica LLC Issues Voluntary Nationwide Recall of Quinacrine Dihydrochloride Due to A Labeling Error
Drugs
Sep 12
KRS Global Biotechnology, Inc. Issues Voluntary Nationwide Recall of All Human and Animal Sterile Drug Products Due to Lack of Assurance of Sterility
Drugs
FDA Voices: Perspectives from FDA Experts
Delivering New Medicines Without Sacrificing Safety and Efficacy
All drugs approved under the agency’s expedited programs are held to the same approval standards as other FDA drug approvals.
Ensuring Safe, Effective Medical Device Sterilization in Manufacturing
The FDA is working to help ensure this process is carried out in a safe and effective manner.
How the FDA Uses Science to Speed Medical Device Innovation
The MDDT program streamlines the medical device development and review process.
Recently Published Guidances
Sep 13
Format for Traditional and Abbreviated 510(k)s
Biologics, Medical Devices
Sep 13
The Abbreviated 510(k) Program
Biologics, Medical Devices
Sep 13
The Special 510(k) Program
Biologics, Medical Devices